We are independent & ad-supported. We may earn a commission for purchases made through our links.
Advertiser Disclosure
Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.
How We Make Money
We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently of our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.

What Is Tumor Necrosis Factor?

By Sylvie Tremblay
Updated May 17, 2024
Our promise to you
WiseGeek is dedicated to creating trustworthy, high-quality content that always prioritizes transparency, integrity, and inclusivity above all else. Our ensure that our content creation and review process includes rigorous fact-checking, evidence-based, and continual updates to ensure accuracy and reliability.

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

Editorial Standards

At WiseGeek, we are committed to creating content that you can trust. Our editorial process is designed to ensure that every piece of content we publish is accurate, reliable, and informative.

Our team of experienced writers and editors follows a strict set of guidelines to ensure the highest quality content. We conduct thorough research, fact-check all information, and rely on credible sources to back up our claims. Our content is reviewed by subject-matter experts to ensure accuracy and clarity.

We believe in transparency and maintain editorial independence from our advertisers. Our team does not receive direct compensation from advertisers, allowing us to create unbiased content that prioritizes your interests.

Tumor necrosis factors (TNFs) are a family of small proteins that are used to signal cells throughout the body. The family consists of two proteins, designated TNF-α and TNF-β. TNF-α is the most studied of the two proteins and is commonly referred to as simply "tumor necrosis factor." The proteins are involved in controlling cell death, as well as inflammation in the body. Dysregulation of TNF can lead to a number of diseases, including cancer.

The proteins of tumor necrosis factor are classified as cytokines — a large class of proteins responsible for signaling to cells. TNF works by binding to and activating tumor necrosis factor receptor (TNF-R) that is found on the surface of cells. Activation of TNF-R then induces a biological signal within the cell to produce a range of cellular responses. Specifically, when TNF binds to TNF-R, it signals an increase in inflammation in the surrounding area, and can also instruct the cell to undergo programmed cell death. The amount of TNF within the body is closely regulated in order to monitor the amount of cell death and inflammation occurring at any given time.

Binding of tumor necrosis factors to their receptors can become deregulated in the body, leading to a range of diseases. Specifically, TNF has been linked to Crohn’s disease — a disorder where the colon is constantly inflamed. Crohn’s patients have more active TNF signaling to cells in their colon, which triggers sustained inflammation within the colon and causes the Crohn’s disease. Many Crohn’s disease sufferers are prescribed drugs, called tumor necrosis factor inhibitors, which decrease the levels of active TNF in the colon and therefore decrease inflammation to reduce symptoms of the disease.

Tumor necrosis factor has also been implicated in several forms of cancer, such as breast and stomach cancers, which occur when cells that are supposed to undergo cell death fail to do so. In this sense, TNF fights cancer because it triggers cell death of potentially cancerous cells. On the other hand, inflammation is known to play a role in the progression of cancer, where sustained inflammation promotes the growth of tumors. Therefore, although some features of TNF fight cancer by inducing cell death, other features of TNF signaling contribute to cancer by promoting inflammation.

Due to this dual role of TNF in cancer, the overall effects of tumor necrosis factor as a cancer treatment have been a subject of debate in cancer research. This has lead to the development of a number of therapeutics designed to retain the cancer-fighting role of TNF, which diminish its inflammatory effect. To this end, scientists have developed forms of TNF that induce cancer cell death with little inflammation. Additionally, scientists have discovered that treatment of tumors with cocktails of TNF in combination with other therapeutics leads to recession of cancer without inflammation. Ultimately, this research will allow doctors to provide customized treatment with tumor necrosis factors to cancer patients to induce remission of tumors.

WiseGeek is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.
Discussion Comments
By CopperSalmon — On Dec 07, 2014

I think it's still in research stage? The article says ultimately this will lead to customized treatment. Although, I am interested in knowing how far along this research is. Cancer runs in my family. Cancer research is really very interesting if you can get past the technical reading.

By BronzeEagle — On Dec 06, 2014

The article says scientists have developed TNF that induce cancer cell death, with little inflammation. Is it a kind of chemotherapy or a totally different therapy? I have a rare genetic cancer, so this stuff really interests me..

WiseGeek, in your inbox

Our latest articles, guides, and more, delivered daily.

WiseGeek, in your inbox

Our latest articles, guides, and more, delivered daily.